KUBOTA PHARMACEUTICAL HOLDINGS CO LTD 4
4 · KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · Filed Jun 2, 2017
Insider Transaction Report
Form 4
DANSE EDWARD H
Chief Business Officer
Transactions
- Sale
Common Stock
2017-06-01$7.38/sh−1,080$7,970→ 70,134 total
Footnotes (3)
- [F1]On November 30, 2016, the issuer completed its change in place of incorporation, pursuant to which Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation ("Kubota Holdings"), became the publicly traded parent company of the Kubota group of companies. Each issued and outstanding share of common stock of Acucela Inc., a Washington corporation ("Acucela US"), was cancelled and converted into one share of common stock of Kubota Holdings. Pursuant to Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended, Kubota Holdings is the successor issuer to Acucela US.
- [F2]The issuer's common stock trades on the Tokyo Stock Exchange under the code 4596.
- [F3]The sale on this Form 4 was effected pursuant to a non-discretionary, Issuer-mandated sell-to-cover arrangement, in order to cover tax withholding incident to the vesting of shares under the reporting person's restricted stock grant.